Stem cell chief's exit is long overdue
By Editorial,
Sacramento Bee
| 06. 20. 2009
Palo Alto developer Robert Klein II led the ballot campaign in 2004 to create California's stem cell research institute. He wrote the initiative, ensuring that only he would chair the institute's oversight board, which is charged with handling $3 billion in public money.
For more than four years, this page has detailed how Klein's all-powerful control has not been in the best interest of either taxpayers or the stem cell agency, the California Institute for Regenerative Medicine.
Now it appears that Klein will step down from CIRM at the end of 2010 – more than 18 months away.
Klein is an impassioned, tenacious advocate for stem cell research, but he is precisely the wrong person to head a government science agency. Chairing a 29-member board that is far too large and rife with conflicts of interest, Klein has operated the institute in a smothering manner, with little regard to transparency or lines of authority.
Since 2005, Klein has run off talented scientists, such as former CIRM President Zach Hall. He has helped direct millions of dollars to contracts for law...
Related Articles
By Azeen Ghorayshi and Sarah Kliff, The New York Times | 08.12.2024
An emerging movement against in vitro fertilization is driving some doctors and patients in red states to move or destroy frozen embryos.
The embryo migration is most striking in Alabama, where the State Supreme Court ruled in February that embryos...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...
By Beth Duff-Brown, Stanford Institute for Economic Policy Research | 07.12.2024
The debate over in vitro fertilization (IVF) has become a hot-button policy and political issue, despite the medical procedure to help people become pregnant having been mainstream in the United States for nearly half a century.
The Alabama Supreme Court ...